Gastroenterology Report最新文献

筛选
英文 中文
Beyond triglyceride clearance: rethinking hypertriglyceridemia-associated acute pancreatitis in the apoC-III era. 超越甘油三酯清除:重新思考apoC-III时代高甘油三酯血症相关的急性胰腺炎。
IF 4 3区 医学
Gastroenterology Report Pub Date : 2026-09-28 eCollection Date: 2026-02-01 DOI: 10.1093/gastro/goag107
Serge Chooklin, Serhii Chuklin
{"title":"Beyond triglyceride clearance: rethinking hypertriglyceridemia-associated acute pancreatitis in the apoC-III era.","authors":"Serge Chooklin, Serhii Chuklin","doi":"10.1093/gastro/goag107","DOIUrl":"10.1093/gastro/goag107","url":null,"abstract":"<p><p>Hypertriglyceridemia-associated acute pancreatitis (HTG-AP) requires causal attribution rather than reliance on a single triglyceride (TG) threshold. Early TG measurement and assessment of competing or coexisting causes are essential because fasting, fluids, and correction of metabolic stress can produce substantial early TG decline. Severity should be determined by serial organ-function assessment using revised Atlanta and Modified Marshall criteria rather than TG concentration alone. Acute management should prioritize standard pancreatitis care, moderate crystalloid resuscitation, analgesia, early oral or enteral nutrition, and correction of genuine metabolic drivers. Intravenous insulin is appropriate for diabetic ketoacidosis, uncontrolled diabetes, marked hyperglycemia, or clinically important insulin deficiency, but current evidence does not support routine insulin solely for TG lowering in insulin-sufficient patients. Heparin should not be used for TG lowering. Therapeutic plasma exchange (TPE) produces rapid biochemical TG clearance, but randomized and adjusted observational evidence has not established improvement in organ failure, pancreatic necrosis, hospital stay, or mortality. TPE should therefore not be used as routine or rescue TG-lowering therapy; exceptional multidisciplinary deliberation may occur only in narrowly defined circumstances and should not be interpreted as an evidence-based indication or recommendation. After recovery, phenotype-directed assessment using fasting lipids, apolipoprotein B, evaluation of secondary drivers, and selective genetic testing can distinguish familial from multifactorial chylomicronemia and guide prevention. Hepatic apolipoprotein C-III (apoC-III) inhibition currently has the strongest randomized evidence for reducing pancreatitis events in relevant chylomicronemia populations. Management should prioritize prevention of organ injury during the acute episode and prevention of subsequent pancreatitis rather than the fastest possible TG decline.</p>","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":"14 ","pages":"goag107"},"PeriodicalIF":4.0,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13618879/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149076486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Navigating TIPS in the era of ageing and metabolic comorbidity: a contemporary narrative review of risk, resilience, and outcomes. 在老龄化和代谢共病时代导航TIPS:对风险、恢复力和结果的当代叙事回顾。
IF 4 3区 医学
Gastroenterology Report Pub Date : 2026-09-25 eCollection Date: 2026-02-01 DOI: 10.1093/gastro/goag103
Davide Roccarina, Dario Saltini, Chiara Mangini, Antonio Piscopo, Alessio Mastro, Alessandra Barbera, Andrea Salomè Velasco Mayorga, Alessandra Avossa, Lucia Ragozzino, Margherita Falcini, Martina Rosi, Alfredo Vozza, Gianmarco Falcone, Fabrizio Fanelli, Fabio Marra, Sara Montagnese, Filippo Schepis, Francesco Vizzutti
{"title":"Navigating TIPS in the era of ageing and metabolic comorbidity: a contemporary narrative review of risk, resilience, and outcomes.","authors":"Davide Roccarina, Dario Saltini, Chiara Mangini, Antonio Piscopo, Alessio Mastro, Alessandra Barbera, Andrea Salomè Velasco Mayorga, Alessandra Avossa, Lucia Ragozzino, Margherita Falcini, Martina Rosi, Alfredo Vozza, Gianmarco Falcone, Fabrizio Fanelli, Fabio Marra, Sara Montagnese, Filippo Schepis, Francesco Vizzutti","doi":"10.1093/gastro/goag103","DOIUrl":"10.1093/gastro/goag103","url":null,"abstract":"<p><p>The ageing of the cirrhotic population, together with the epidemiological shift toward metabolic dysfunction-associated steatohepatitis, is redefining the profile of patients referred for transjugular intrahepatic portosystemic shunt (TIPS). Although TIPS remains a cornerstone in the management of complications of portal hypertension, its abrupt hemodynamic and metabolic effects challenge the physiological reserve of multiple organ systems. Age-related cardiovascular remodeling, cirrhotic cardiomyopathy, impaired renal function and autoregulation, and reduced neurocognitive reserve interact with the hyperdynamic circulatory state of cirrhosis increasing the susceptibility to heart failure, acute kidney injury (AKI), and hepatic encephalopathy following TIPS. This vulnerability is further amplified by metabolic comorbidities, obesity, sarcopenia, frailty, and age-related alterations of the gut microbiota and gut-liver axis, which collectively promote systemic inflammation, immune dysregulation, endothelial dysfunction, and reduced metabolic adaptability. Rather than independently, these factors shape an interconnected heart-liver-kidney-brain network in which dysfunction in one domain may rapidly propagate to others. This review summarizes how ageing influences the cardiovascular, renal, neurological, and metabolic response to TIPS, critically appraises current strategies for pre-procedural risk assessment, and discusses approaches to improve patient selection and peri-procedural management. Because chronological age alone inadequately reflects procedural risk and clinical outcomes, TIPS evaluation should incorporate a structured assessment of biological ageing, including cardiovascular and renal reserve, neurocognitive vulnerability, sarcopenia, frailty, body-composition phenotype, and metabolic burden. Integrating these domains into pre-procedural assessment may improve patient selection, inform shunt sizing, and ultimately optimize outcomes in this rapidly evolving patient population.</p>","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":"14 ","pages":"goag103"},"PeriodicalIF":4.0,"publicationDate":"2026-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13613062/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149065891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic ultrasound-guided hepaticogastrostomy with a 22-G needle and novel double-lumen catheter after pancreaticoduodenectomy. 内镜下超声引导下22g针加新型双腔导管胰十二指肠切除术后肝胃造口术。
IF 4 3区 医学
Gastroenterology Report Pub Date : 2026-09-18 eCollection Date: 2026-02-01 DOI: 10.1093/gastro/goag097
Toru Kaneko, Mitsuhiro Kida, Takahiro Kurosu, Yuta Sakabe, Shiori Koyama, Hisashi Hidaka, Chika Kusano
{"title":"Endoscopic ultrasound-guided hepaticogastrostomy with a 22-G needle and novel double-lumen catheter after pancreaticoduodenectomy.","authors":"Toru Kaneko, Mitsuhiro Kida, Takahiro Kurosu, Yuta Sakabe, Shiori Koyama, Hisashi Hidaka, Chika Kusano","doi":"10.1093/gastro/goag097","DOIUrl":"10.1093/gastro/goag097","url":null,"abstract":"","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":"14 ","pages":"goag097"},"PeriodicalIF":4.0,"publicationDate":"2026-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13588573/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149009514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rare cause of liver cirrhosis in an adult. 成人肝硬化的罕见病因。
IF 4 3区 医学
Gastroenterology Report Pub Date : 2026-09-17 eCollection Date: 2026-02-01 DOI: 10.1093/gastro/goag069
Shuxiang Li, Weijia Duan, Guanhua Zhang, Xiaojuan Ou, Jidong Jia, Xinyan Zhao
{"title":"A rare cause of liver cirrhosis in an adult.","authors":"Shuxiang Li, Weijia Duan, Guanhua Zhang, Xiaojuan Ou, Jidong Jia, Xinyan Zhao","doi":"10.1093/gastro/goag069","DOIUrl":"10.1093/gastro/goag069","url":null,"abstract":"","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":"14 ","pages":"goag069"},"PeriodicalIF":4.0,"publicationDate":"2026-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13585457/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148992325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is high-quality robotic surgery a solo performance by the console surgeon? 高质量的机器人手术是由控制台外科医生独自完成的吗?
IF 4 3区 医学
Gastroenterology Report Pub Date : 2026-09-16 eCollection Date: 2026-02-01 DOI: 10.1093/gastro/goag102
Jun Lu, Junwei Zou, Youdong Liu, Fenglin Liu
{"title":"Is high-quality robotic surgery a solo performance by the console surgeon?","authors":"Jun Lu, Junwei Zou, Youdong Liu, Fenglin Liu","doi":"10.1093/gastro/goag102","DOIUrl":"https://doi.org/10.1093/gastro/goag102","url":null,"abstract":"","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":"14 ","pages":"goag102"},"PeriodicalIF":4.0,"publicationDate":"2026-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13579155/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148992273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-time AI assistance improves adherence to standardized biliopancreatic EUS examination: a real-world comparative study. 实时人工智能辅助提高对标准化胆胰EUS检查的依从性:一项现实世界的比较研究。
IF 4 3区 医学
Gastroenterology Report Pub Date : 2026-09-12 eCollection Date: 2026-02-01 DOI: 10.1093/gastro/goag078
Chenxia Zhang, Jun Zhang, Wei Tan, Xiao Tao, Wei Zhou, Bing Xiao, Honggang Yu
{"title":"Real-time AI assistance improves adherence to standardized biliopancreatic EUS examination: a real-world comparative study.","authors":"Chenxia Zhang, Jun Zhang, Wei Tan, Xiao Tao, Wei Zhou, Bing Xiao, Honggang Yu","doi":"10.1093/gastro/goag078","DOIUrl":"10.1093/gastro/goag078","url":null,"abstract":"<p><strong>Background: </strong>Biliopancreatic endoscopic ultrasound (EUS) is highly operator-dependent, and adherence to standardized examination pathways may vary in routine practice. Evidence on whether real-time artificial intelligence (AI) assistance improves adherence to standardized biliopancreatic EUS examination in real-world settings remains limited.</p><p><strong>Methods: </strong>We conducted a retrospective comparative cohort study at a tertiary referral center to evaluate the real-world implementation of a real-time AI assistance system during biliopancreatic EUS. Examinations from the pre-AI period were compared with those from the post-AI period after a washout interval. Propensity score matching and interrupted time-series analysis were used to reduce baseline imbalance and assess temporal changes. The primary outcome was adherence to the standardized examination protocol, operationalized as total documentation completeness across eight predefined anatomical stations. Secondary outcomes included station-level adherence and lesion detection, with prespecified evaluation of pancreatic masses smaller than 2 cm.</p><p><strong>Results: </strong>Among 1,465 eligible examinations, 854 matched examinations (427 per group) were analyzed. Adherence to the standardized eight-station examination was higher in the post-AI group, reflected by greater total documentation completeness (89.93% vs 81.29%, adjusted absolute difference 8.65%, 95% confidence interval [CI] 6.58-10.71, <i>P </i>< 0.001). Detection of pancreatic masses smaller than 2 cm was also higher after AI implementation (11.48% vs 6.56%, adjusted odds ratio 1.82, 95% CI 1.13-3.01, <i>P </i>= 0.016).</p><p><strong>Conclusions: </strong>In this real-world comparative study, real-time AI assistance was associated with greater adherence to a standardized biliopancreatic EUS examination protocol and a higher observed detection rate of pancreatic masses smaller than 2 cm. These findings suggest that real-time AI assistance may facilitate more standardized biliopancreatic EUS examination in routine practice.</p>","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":"14 ","pages":"goag078"},"PeriodicalIF":4.0,"publicationDate":"2026-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13570796/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148957297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combination interleukin-23p19 inhibitor and Janus kinase inhibitor rescue for steroid-refractory acute severe ulcerative colitis in pregnancy complicated by primary sclerosing cholangitis. 白细胞介素-23p19抑制剂联合Janus激酶抑制剂抢救妊娠期类固醇难治性急性重度溃疡性结肠炎合并原发性硬化性胆管炎。
IF 4 3区 医学
Gastroenterology Report Pub Date : 2026-09-11 eCollection Date: 2026-02-01 DOI: 10.1093/gastro/goag095
Mohammed Nabil Quraishi, Nadeen Omar, Hatim Taha, Sherina AlShamshi, Menatullah Fadda, Zaher Koutoubi
{"title":"Combination interleukin-23p19 inhibitor and Janus kinase inhibitor rescue for steroid-refractory acute severe ulcerative colitis in pregnancy complicated by primary sclerosing cholangitis.","authors":"Mohammed Nabil Quraishi, Nadeen Omar, Hatim Taha, Sherina AlShamshi, Menatullah Fadda, Zaher Koutoubi","doi":"10.1093/gastro/goag095","DOIUrl":"10.1093/gastro/goag095","url":null,"abstract":"","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":"14 ","pages":"goag095"},"PeriodicalIF":4.0,"publicationDate":"2026-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13568818/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148957301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Citation integrity in the AI era: a focused evidence map and layered verification framework for gastroenterology and hepatology publishing. 人工智能时代的引文完整性:胃肠病学和肝病学出版的集中证据图和分层验证框架。
IF 4 3区 医学
Gastroenterology Report Pub Date : 2026-09-09 eCollection Date: 2026-02-01 DOI: 10.1093/gastro/goag098
Eun-Ae Jung, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
{"title":"Citation integrity in the AI era: a focused evidence map and layered verification framework for gastroenterology and hepatology publishing.","authors":"Eun-Ae Jung, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim","doi":"10.1093/gastro/goag098","DOIUrl":"10.1093/gastro/goag098","url":null,"abstract":"","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":"14 ","pages":"goag098"},"PeriodicalIF":4.0,"publicationDate":"2026-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13557618/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148921937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protrusion of nasobiliary drainage catheter through the anus. 鼻胆管引流管经肛门突出。
IF 4 3区 医学
Gastroenterology Report Pub Date : 2026-09-08 eCollection Date: 2026-02-01 DOI: 10.1093/gastro/goag086
Dongrui Li, Yuanbo Bi, Shengxiong Chen, Tengfei Zhang, Yunfei Liang, Jiansheng Zhang
{"title":"Protrusion of nasobiliary drainage catheter through the anus.","authors":"Dongrui Li, Yuanbo Bi, Shengxiong Chen, Tengfei Zhang, Yunfei Liang, Jiansheng Zhang","doi":"10.1093/gastro/goag086","DOIUrl":"10.1093/gastro/goag086","url":null,"abstract":"","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":"14 ","pages":"goag086"},"PeriodicalIF":4.0,"publicationDate":"2026-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13552377/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148914339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world management of SeHCAT-confirmed bile acid diarrhoea: response to colestyramine and predictors of treatment success. sehcat确认的胆汁酸腹泻的实际管理:对胆胱胺的反应和治疗成功的预测因素。
IF 4 3区 医学
Gastroenterology Report Pub Date : 2026-09-03 eCollection Date: 2026-02-01 DOI: 10.1093/gastro/goag090
Eduard Brunet-Mas, Andrea Peña-Rosado, Belen Garcia-Sagué, Luis Enrique Frisancho, Luigi Melcarne, Laura Patricia Llovet, Anna Puy, Maria José Ramírez-Lázaro, Antonio Rodriguez Revuelto, Alberto Villoria, Xavier Calvet, Sergio Lario
{"title":"Real-world management of SeHCAT-confirmed bile acid diarrhoea: response to colestyramine and predictors of treatment success.","authors":"Eduard Brunet-Mas, Andrea Peña-Rosado, Belen Garcia-Sagué, Luis Enrique Frisancho, Luigi Melcarne, Laura Patricia Llovet, Anna Puy, Maria José Ramírez-Lázaro, Antonio Rodriguez Revuelto, Alberto Villoria, Xavier Calvet, Sergio Lario","doi":"10.1093/gastro/goag090","DOIUrl":"10.1093/gastro/goag090","url":null,"abstract":"<p><strong>Background: </strong>Bile acid diarrhoea (BAD) is an increasingly recognized cause of chronic diarrhoea. The 75-selenium homocholic acid taurine (SeHCAT) test remains the gold standard for diagnosis. The primary pharmacological treatment involves bile acid-binding agents, most commonly colestyramine. This study aimed to review the management of BAD at our centre and to identify factors associated with response to colestyramine.</p><p><strong>Materials and methods: </strong>This single-centre retrospective study included all patients with an abnormal SeHCAT test (retention <15%) from 1 January 2020 to 31 December 2023 associated with chronic diarrhoea. Patients receiving empiric bile acid chelators without prior SeHCAT testing and those under 18 years of age were excluded. The primary endpoint was treatment success with colestyramine, defined as complete or partial clinical response without treatment discontinuation due to intolerance. Univariable comparisons and multivariable logistic regression were performed to identify factors independently associated with treatment success.</p><p><strong>Results: </strong>Ninety-seven patients were included; 72.2% were women, with a mean age of 54.4 ± 15.1 years. Severe BAD was observed in 60.8% of cases. Overall, 77.3% of patients responded to colestyramine (43.2% complete, 34.0% partial). In multivariable analysis, baseline higher number of bowel movements per day was independently associated with a lower probability of treatment success (odds ratio 0.79, 95% confidence interval 0.68-0.92; <i>P </i>= 0.003). Colestyramine failure was generally due to intolerance-related discontinuation (17.5% of the cohort) followed by lack of efficacy (5.1%). No severe adverse events were documented.</p><p><strong>Conclusion: </strong>Colestyramine appears to be an effective first-line therapy for BAD in routine clinical practice. However, treatment success in this study reflects both clinical response and tolerability, as treatment failure was more frequently related to intolerance than lack of efficacy.</p>","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":"14 ","pages":"goag090"},"PeriodicalIF":4.0,"publicationDate":"2026-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13541380/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148892818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书